Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Medical Sciences Division News

Professor Mina Fazel appointed Chair of Child and Adolescent Psychiatry

She will lead the Child and Adolescent Psychiatry research group, aiming to better understand how to prevent mental health difficulties in children and young people and how best to support them and their families

New heart disease calculator could save lives by identifying high-risk patients missed by current tools

Collaborative research, led by the Nuffield Department of Primary Care Health Sciences (NDPCHS) and published today in Nature Medicine, has developed a new tool called QR4 that more accurately predicts an individual's 10-year risk of cardiovascular diseases, like heart disease and stroke, particularly identifying high-risk patients that current prediction tools miss.

New trial using skin patches as an ‘early warning system’ to spot lung transplant rejection

A new trial, SENTINEL, is set to investigate if skin patches can be used as an early warning system to identify if lung transplants are being rejected, so treatment can begin sooner, reducing the chance of longer lasting organ damage.

Serum Institute of India and University of Oxford strike landmark licensing agreement for Meningitis-B vaccine

Serum Institute of India Pvt. Ltd (SIIPL), in collaboration with the University of Oxford, is developing a novel solution for Men-B disease, advancing global accessibility to life-saving vaccines.

Breakthrough aerosol human infection model gives hope for future tuberculosis vaccine development

University of Oxford researchers have for the first time established a controlled human infection model for tuberculosis (TB) that infects people via the lungs – the way TB enters the body.